- Home
- TOPS vs RADX Comparison
TOPS vs RADX Comparison
Compare TOPS & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- RADX
- Stock Information
- Founded
- TOPS 2000
- RADX 2021
- Country
- TOPS Greece
- RADX Australia
- Employees
- TOPS N/A
- RADX N/A
- Industry
- TOPS Marine Transportation
- RADX
- Sector
- TOPS Consumer Discretionary
- RADX
- Exchange
- TOPS Nasdaq
- RADX NYSE
- Market Cap
- TOPS 27.2M
- RADX 32.5M
- IPO Year
- TOPS 2004
- RADX N/A
- Fundamental
- Price
- TOPS $6.15
- RADX $4.43
- Analyst Decision
- TOPS
- RADX Strong Buy
- Analyst Count
- TOPS 0
- RADX 2
- Target Price
- TOPS N/A
- RADX $13.50
- AVG Volume (30 Days)
- TOPS 58.2K
- RADX 20.0K
- Earning Date
- TOPS 08-08-2025
- RADX 02-26-2025
- Dividend Yield
- TOPS N/A
- RADX N/A
- EPS Growth
- TOPS N/A
- RADX N/A
- EPS
- TOPS 1.09
- RADX N/A
- Revenue
- TOPS $86,127,000.00
- RADX $204,609.00
- Revenue This Year
- TOPS $9.90
- RADX N/A
- Revenue Next Year
- TOPS N/A
- RADX N/A
- P/E Ratio
- TOPS $5.65
- RADX N/A
- Revenue Growth
- TOPS 3.83
- RADX N/A
- 52 Week Low
- TOPS $5.00
- RADX $3.50
- 52 Week High
- TOPS $11.47
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- TOPS 50.43
- RADX N/A
- Support Level
- TOPS $5.81
- RADX N/A
- Resistance Level
- TOPS $6.55
- RADX N/A
- Average True Range (ATR)
- TOPS 0.34
- RADX 0.00
- MACD
- TOPS 0.04
- RADX 0.00
- Stochastic Oscillator
- TOPS 72.41
- RADX 0.00
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.